Cargando…

Insulin Resistance Promotes Parkinson’s Disease through Aberrant Expression of α-Synuclein, Mitochondrial Dysfunction, and Deregulation of the Polo-Like Kinase 2 Signaling

Background: Insulin resistance (IR), considered a hallmark of diabetes at the cellular level, is implicated in pre-diabetes, results in type 2 diabetes, and negatively affects mitochondrial function. Diabetes is increasingly associated with enhanced risk of developing Parkinson’s disease (PD); howev...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Chien-Tai, Chen, Kai-Yun, Wang, Weu, Chiu, Jing-Yuan, Wu, Dean, Chao, Tsu-Yi, Hu, Chaur-Jong, Chau, Kai-Yin David, Bamodu, Oluwaseun Adebayo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140619/
https://www.ncbi.nlm.nih.gov/pubmed/32192190
http://dx.doi.org/10.3390/cells9030740
_version_ 1783519031881367552
author Hong, Chien-Tai
Chen, Kai-Yun
Wang, Weu
Chiu, Jing-Yuan
Wu, Dean
Chao, Tsu-Yi
Hu, Chaur-Jong
Chau, Kai-Yin David
Bamodu, Oluwaseun Adebayo
author_facet Hong, Chien-Tai
Chen, Kai-Yun
Wang, Weu
Chiu, Jing-Yuan
Wu, Dean
Chao, Tsu-Yi
Hu, Chaur-Jong
Chau, Kai-Yin David
Bamodu, Oluwaseun Adebayo
author_sort Hong, Chien-Tai
collection PubMed
description Background: Insulin resistance (IR), considered a hallmark of diabetes at the cellular level, is implicated in pre-diabetes, results in type 2 diabetes, and negatively affects mitochondrial function. Diabetes is increasingly associated with enhanced risk of developing Parkinson’s disease (PD); however, the underlying mechanism remains unclear. This study investigated the probable culpability of IR in the pathogenesis of PD. Methods: Using MitoPark mice in vivo models, diabetes was induced by a high-fat diet in the in vivo models, and IR was induced by protracted pulse-stimulation with 100 nM insulin treatment of neuronal cells, in vitro to determine the molecular mechanism(s) underlying altered cellular functions in PD, including mitochondrial dysfunction and α-synuclein (SNCA) aberrant expression. Findings: We observed increased SNCA expression in the dopaminergic (DA) neurons of both the wild-type and diabetic MitoPark mice, coupled with enhanced degeneration of DA neurons in the diabetic MitoPark mice. Ex vivo, in differentiated human DA neurons, IR was associated with increased SNCA and reactive oxygen species (ROS) levels, as well as mitochondrial depolarization. Moreover, we demonstrated concomitant hyperactivation of polo-like kinase-2 (PLK2), and upregulated p-SNCA (Ser129) and proteinase K-resistant SNCA proteins level in IR SH-SY5Y cells, however the inhibition of PLK2 reversed IR-related increases in phosphorylated and total SNCA. Similarly, the overexpression of peroxisome proliferator-activated receptor-γ coactivator 1-alpha (PGC)-1α suppressed ROS production, repressed PLK2 hyperactivity, and resulted in downregulation of total and Ser129-phosphorylated SNCA in the IR SH-SY5Y cells. Conclusions: These findings demonstrate that IR-associated diabetes promotes the development and progression of PD through PLK2-mediated mitochondrial dysfunction, upregulated ROS production, and enhanced SNCA signaling, suggesting the therapeutic targetability of PLK2 and/or SNCA as potential novel disease-modifying strategies in patients with PD.
format Online
Article
Text
id pubmed-7140619
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-71406192020-04-13 Insulin Resistance Promotes Parkinson’s Disease through Aberrant Expression of α-Synuclein, Mitochondrial Dysfunction, and Deregulation of the Polo-Like Kinase 2 Signaling Hong, Chien-Tai Chen, Kai-Yun Wang, Weu Chiu, Jing-Yuan Wu, Dean Chao, Tsu-Yi Hu, Chaur-Jong Chau, Kai-Yin David Bamodu, Oluwaseun Adebayo Cells Article Background: Insulin resistance (IR), considered a hallmark of diabetes at the cellular level, is implicated in pre-diabetes, results in type 2 diabetes, and negatively affects mitochondrial function. Diabetes is increasingly associated with enhanced risk of developing Parkinson’s disease (PD); however, the underlying mechanism remains unclear. This study investigated the probable culpability of IR in the pathogenesis of PD. Methods: Using MitoPark mice in vivo models, diabetes was induced by a high-fat diet in the in vivo models, and IR was induced by protracted pulse-stimulation with 100 nM insulin treatment of neuronal cells, in vitro to determine the molecular mechanism(s) underlying altered cellular functions in PD, including mitochondrial dysfunction and α-synuclein (SNCA) aberrant expression. Findings: We observed increased SNCA expression in the dopaminergic (DA) neurons of both the wild-type and diabetic MitoPark mice, coupled with enhanced degeneration of DA neurons in the diabetic MitoPark mice. Ex vivo, in differentiated human DA neurons, IR was associated with increased SNCA and reactive oxygen species (ROS) levels, as well as mitochondrial depolarization. Moreover, we demonstrated concomitant hyperactivation of polo-like kinase-2 (PLK2), and upregulated p-SNCA (Ser129) and proteinase K-resistant SNCA proteins level in IR SH-SY5Y cells, however the inhibition of PLK2 reversed IR-related increases in phosphorylated and total SNCA. Similarly, the overexpression of peroxisome proliferator-activated receptor-γ coactivator 1-alpha (PGC)-1α suppressed ROS production, repressed PLK2 hyperactivity, and resulted in downregulation of total and Ser129-phosphorylated SNCA in the IR SH-SY5Y cells. Conclusions: These findings demonstrate that IR-associated diabetes promotes the development and progression of PD through PLK2-mediated mitochondrial dysfunction, upregulated ROS production, and enhanced SNCA signaling, suggesting the therapeutic targetability of PLK2 and/or SNCA as potential novel disease-modifying strategies in patients with PD. MDPI 2020-03-17 /pmc/articles/PMC7140619/ /pubmed/32192190 http://dx.doi.org/10.3390/cells9030740 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Hong, Chien-Tai
Chen, Kai-Yun
Wang, Weu
Chiu, Jing-Yuan
Wu, Dean
Chao, Tsu-Yi
Hu, Chaur-Jong
Chau, Kai-Yin David
Bamodu, Oluwaseun Adebayo
Insulin Resistance Promotes Parkinson’s Disease through Aberrant Expression of α-Synuclein, Mitochondrial Dysfunction, and Deregulation of the Polo-Like Kinase 2 Signaling
title Insulin Resistance Promotes Parkinson’s Disease through Aberrant Expression of α-Synuclein, Mitochondrial Dysfunction, and Deregulation of the Polo-Like Kinase 2 Signaling
title_full Insulin Resistance Promotes Parkinson’s Disease through Aberrant Expression of α-Synuclein, Mitochondrial Dysfunction, and Deregulation of the Polo-Like Kinase 2 Signaling
title_fullStr Insulin Resistance Promotes Parkinson’s Disease through Aberrant Expression of α-Synuclein, Mitochondrial Dysfunction, and Deregulation of the Polo-Like Kinase 2 Signaling
title_full_unstemmed Insulin Resistance Promotes Parkinson’s Disease through Aberrant Expression of α-Synuclein, Mitochondrial Dysfunction, and Deregulation of the Polo-Like Kinase 2 Signaling
title_short Insulin Resistance Promotes Parkinson’s Disease through Aberrant Expression of α-Synuclein, Mitochondrial Dysfunction, and Deregulation of the Polo-Like Kinase 2 Signaling
title_sort insulin resistance promotes parkinson’s disease through aberrant expression of α-synuclein, mitochondrial dysfunction, and deregulation of the polo-like kinase 2 signaling
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140619/
https://www.ncbi.nlm.nih.gov/pubmed/32192190
http://dx.doi.org/10.3390/cells9030740
work_keys_str_mv AT hongchientai insulinresistancepromotesparkinsonsdiseasethroughaberrantexpressionofasynucleinmitochondrialdysfunctionandderegulationofthepololikekinase2signaling
AT chenkaiyun insulinresistancepromotesparkinsonsdiseasethroughaberrantexpressionofasynucleinmitochondrialdysfunctionandderegulationofthepololikekinase2signaling
AT wangweu insulinresistancepromotesparkinsonsdiseasethroughaberrantexpressionofasynucleinmitochondrialdysfunctionandderegulationofthepololikekinase2signaling
AT chiujingyuan insulinresistancepromotesparkinsonsdiseasethroughaberrantexpressionofasynucleinmitochondrialdysfunctionandderegulationofthepololikekinase2signaling
AT wudean insulinresistancepromotesparkinsonsdiseasethroughaberrantexpressionofasynucleinmitochondrialdysfunctionandderegulationofthepololikekinase2signaling
AT chaotsuyi insulinresistancepromotesparkinsonsdiseasethroughaberrantexpressionofasynucleinmitochondrialdysfunctionandderegulationofthepololikekinase2signaling
AT huchaurjong insulinresistancepromotesparkinsonsdiseasethroughaberrantexpressionofasynucleinmitochondrialdysfunctionandderegulationofthepololikekinase2signaling
AT chaukaiyindavid insulinresistancepromotesparkinsonsdiseasethroughaberrantexpressionofasynucleinmitochondrialdysfunctionandderegulationofthepololikekinase2signaling
AT bamoduoluwaseunadebayo insulinresistancepromotesparkinsonsdiseasethroughaberrantexpressionofasynucleinmitochondrialdysfunctionandderegulationofthepololikekinase2signaling